Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010;266(1):90-7.
doi: 10.1016/j.cellimm.2010.09.002. Epub 2010 Sep 17.

Memory B cells from older people express normal levels of cyclooxygenase-2 and produce higher levels of IL-6 and IL-10 upon in vitro activation

Affiliations

Memory B cells from older people express normal levels of cyclooxygenase-2 and produce higher levels of IL-6 and IL-10 upon in vitro activation

Simona Bancos et al. Cell Immunol. 2010.

Abstract

Worldwide the elderly population is increasing. The elderly show deficiencies in immune function. B lymphocytes are essential elements of the immune system responsible for antibody production. This laboratory previously showed that activated human B cells isolated from young adults express cyclooxygenase-2 (Cox-2) and that Cox-2 is essential for optimal antibody responses. Recent data suggests that Cox-2 expression decreases with age in mouse bone tissue. There is no information regarding Cox-2 expression in B cells from older human subjects. We investigated the expression and activity of Cox-2 in naïve and memory B cells from older people. We show that B cells from older subjects show similar Cox-2 protein expression and activity, antibody production and proliferation compared to younger people. However, we found that activated memory B cells from older people produce higher levels of IL-6 and IL-10 compared to young adults. Therefore, the dysregulated cytokine production could contribute to immune senescence in the elderly.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Older people show a lower percentage of naïve B cells but a higher percentage of memory B cells in their peripheral blood
Peripheral blood was collected from young (18-35 years old; n= 8) and older (over 60 years old; n= 9) people and peripheral blood mononuclear cells (PBMCs) were isolated by Ficoll gradient centrifugation, stained with CD19 and CD27 antibodies and analyzed on a Becton Dickinson LSRII. A. Young volunteers have ~75% naïve B cells (CD19+CD27) whereas older volunteers have a significantly lower percentage of naïve B cells (~40%). B. Older volunteers have an increased percentage (~60%) of memory B cells (CD19+CD27+) whereas young volunteers have ~ 25% memory B cells in the peripheral blood. Graphs show the mean and SEM. *, p< 0.05 was calculated using the Mann-Whitney test. Student's t test gave similar results (**, p= 0.0087 for Figure 1A and **, p=0.0059 for Figure 1B).
Figure 2
Figure 2. Naïve and memory B cells from older people increase Cox-2 expression upon activation
Sorted naïve and memory B cells from young (n= 8) and older (n= 8) people were stimulated with anti-Ig plus CpG 2395 for 2 days. Cells were stained with an anti-Cox-2 antibody and analyzed on a Becton Dickinson LSRII. Graphs show the mean fluorescence intensity (MFI) of Cox-2 staining. A and B. Naïve and memory B cells from both young and older people increased Cox-2 expression upon activation. Untreated cells show a lower MFI (~500) compared to activated cells (~ 800 for young and ~1,100 for memory from older people). Graphs show the mean and SEM. *, p< 0.05 and **, p< 0.005 was calculated using the Mann-Whitney test. Analysis using Student's t test resulted in: Figure 2A: ***, p= 0.0002 (when comparing young (no treatment) to young (aIg+ CpG 2395) and *, p= 0.0472 (when comparing older (no treatment) to older (aIg+CpG 2395) samples; Figure 2B: **, p= 0.0037 for young (no treatment) versus young (aIg+CpG) and p= 0.064 (not significant) when comparing older (no treatment) to older (aIg+CpG 2395). There is no significant statistical difference between young (aIg+ CpG 2395) and older (aIg+ CpG 2395) samples.
Figure 3
Figure 3. Naïve and memory B cells from older people increase PGE2 synthesis upon activation
Sorted naïve and memory B cells from young (n= 9) and older (n= 8) people were stimulated with anti-Ig plus CpG 2395 for 2 days after which supernatants were harvested and used for PGE2 detection. Unactivated naïve and memory B cells produce ~ 75 pg/ml PGE2 whereas activated naïve and memory B cells (from both young and older subjects) produce ~150 pg/ml PGE2. Graphs show the mean and SEM. *, p< 0.05, **, p< 0.005 and ***, p<0.0001 was calculated using the Mann-Whitney test. According to Student's t test the p values are: Figure 3A: *, p=0.013 for young (no treatment) versus young (aIg+ CpG 2395) and **, p= 0.004 for older (no treatment) versus older (aIg+ CpG 2395); Figure 3B: ***, p=0.003 for young (no treatment) versus young (aIg+ CpG 2395) and ***, p< 0.0001 for older (no treatment) versus older (aIg+ CpG 2395). There is no significant statistical difference between young (aIg+ CpG 2395) and older (aIg+ CpG 2395) samples.
Figure 4
Figure 4. Naïve and memory B cells from older people increase expression of CD69 and proliferate after in vitro activation
Sorted naïve and memory B cells from young and older people were activated in vitro with anti-Ig plus CpG 2395. On day 2 cells were harvested and stained for CD69 after which cells were analyzed on a Beckton Dickinson LSRII. A and B show the histograms of CD69 expression in anti-Ig plus CpG 2395 activated (black line) compared to no treatment (gray contour) naïve and memory B cells. The histograms are representative for naïve and memory B cells in young and older people. C and D show the fold induction in CD69 MFI of activated cells versus no treatment cells. There is an increase in CD69 MFI in both naïve and memory B cells from young (n=7) and older (n=7) subjects. [3H]-thymidine was added to the activated naïve and memory B cells from young and older people and proliferation was assayed (E and F). Graphs show the mean and SEM of counts per minute (cpm) from young (n= 4) and older (n= 5) people. Naïve and memory B cells showed similar proliferation patterns and there are no significant differences between the two age groups.
Figure 5
Figure 5. B cells from older people produce similar levels of antibodies compared to younger subjects
Sorted naïve and memory B cells from young and older people were activated with anti-Ig plus CpG 2395 for 7 days after which supernatants were harvested and used to determine IgM and IgG production. A and B. Activated naïve B cells from young and older people synthesize similar levels of IgM (~8,000 ng/ml) and IgG (~200 ng/ml). C and D. Activated memory B cells from older people produce more IgM (~70,000 ng/ml) but similar levels of IgG (~4,000 ng/ml) compared to young subjects (~25,000 ng/ml and ~ 4,000 ng/ml, respectively). Graphs show the mean and SEM.
Figure 6
Figure 6. Activated memory B cells from older people increased IL-6 and IL-10 levels
Sorted naïve and memory B cells from young and older people were stimulated with anti-Ig plus CpG 2395 for 2 days after which supernatants were harvested and used for IL-6 and IL-10 detection. A Naïve B cells from young and older subjects produce similar levels of IL-6 (~2,000 pg/ml). B. Memory B cells from older people produce significantly more IL-6 (~3,000 pg/ml) as compared to young subjects (~1,000 pg/ml). C. Naïve B cells from older people produce slightly more IL-10 (~1,500 pg/ml) compared to naïve B cells from young people (~700 pg/ml). D. Memory B cells from older people produce significantly more IL-10 (~1,600 pg/ml) compared to young subjects (~250 pg/ml). **, p< 0.005 was calculated using the Mann-Whitney test. The p values according to t test were: Figure 6B, ***, p= 0.0009 and Figure 6D, *, p= 0.035.

Similar articles

Cited by

References

    1. Ryan EP, Pollock SJ, Murant TI, Bernstein SH, Felgar RE, Phipps RP. Activated human B lymphocytes express cyclooxygenase-2 and cyclooxygenase inhibitors attenuate antibody production. J. Immunol. 2005;174:2619–2626. - PubMed
    1. Harris SG, Padilla J, Koumas L, Ray D, Phipps RP. Prostaglandins as modulators of immunity. Trends Immunol. 2002;23:144–150. - PubMed
    1. Davies P, Bailey PJ, Goldenberg MM, Ford-Hutchinson AW. The role of arachidonic acid oxygenation products in pain and inflammation. Annu. Rev. Immunol. 1984;2:335–357. - PubMed
    1. Langman MJ. Ulcer complications and nonsteroidal anti-inflammatory drugs. Am. J. Med. 1988;84:15–19. - PubMed
    1. Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat. Immunol. 2004;5:133–139. - PubMed

Publication types

MeSH terms